Table 5 Treatment and outcome of PCR-confirmed influenza patients in Bavarian PICUs, 2010–2013. Data are shown by virus type/subtype (n = 47)a
Influenza type/subtype | Comparison of seasons | ||||||
|---|---|---|---|---|---|---|---|
A(H1N1)pdm09c | |||||||
Treatment | All | A | A(H1N1)pdm09 | A(H3N2) | A (subtype n.a.) | B | S1 vs S3 |
N = 47 | N = 40 | N = 32 | N = 4 | N = 4 | N = 7 | p-value* | |
Antiviral drugsb; n (%) | 13 (27.7) | 12 (30.0) | 9 (28.1) | 1 (25.0) | 2 (50.0) | 1 (14.3) | 1.000 |
Antibiotics i.v.; n (%) | 34 (72.3) | 31 (77.5) | 25 (78.1) | 2 (50.0) | 4 (100.0) | 3 (42.9) | 0.676 |
Antipyretics; n (%) | 33 (70.2) | 28 (70.0) | 22 (68.8) | 2 (50.0) | 4 (100.0) | 5 (71.4) | 0.452 |
Catecholamines; n (%) | 13 (27.7) | 13 (32.5) | 11 (34.4) | 1 (25.0) | 1 (25.0) | 0 (0.0) | 1.000 |
Inhalation therapy; n (%) | 13 (27.7) | 13 (32.5) | 11 (34.4) | 2 (50.0) | 0 (0.0) | 0 (0.0) | 1.000 |
Oxygen; n (%) | 31 (66.0) | 28 (70.0) | 20 (62.5) | 4 (100.0) | 4 (100.0.) | 3 (42.9) | 0.275 |
Intratracheal ventilation; n (%) | 15 (31.9) | 14 (35.0) | 12 (37.5) | 1 (25.0) | 1 (25.0) | 1 (14.3) | 1.000 |
CPAP; n (%) | 11 (23.4) | 9 (22.5) | 7 (21.9) | 0 (0.0) | 2 (50.0) | 2 (28.6) | 0.084 |
Other; n (%) | 14 (29.8) | 13 (32.5) | 10 (31.3) | 2 (50.0) | 1 (25.0) | 1 (14.3) | 0.247 |
Outcome | |||||||
Sequelae; n (%) | 5 (10.6) | 4 (10.0) | 3 (9.4) | 1 (25.0) | 0 (0.0) | 1 (14.3) | 0.548 |
Death; n (%) | 5 (10.6) | 5 (12.5) | 5 (15.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1.000 |